Richard Rhodes
Pulmonary Disease · Indianapolis, INNPI 1881698272
Payments from drug & device makers
Across 186 payments — averaging $22.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Grifols USA, LLC$628
- Genentech USA, Inc.$499
- GSK$443
- Boehringer Ingelheim$394
- AstraZeneca$385
- Sunovion Pharmaceuticals Inc.$261
- plus $2K from 18 others
What the payments were for
- Food & beverage$4,13299%
- Education$381%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Grifols USA, LLC | 17 | $628 |
| Genentech USA, Inc. | 19 | $499 |
| GSK | 34 | $443 |
| Boehringer Ingelheim | 24 | $394 |
| AstraZeneca(2 entities) | 19 | $385 |
| Sunovion Pharmaceuticals Inc. | 17 | $261 |
| Mylan Specialty L.p. | 7 | $217 |
| Actelion Pharmaceuticals US, Inc. | 4 | $198 |
| Shire North American Group Inc | 4 | $165 |
| AbbVie(2 entities) | 3 | $163 |
| Novartis | 7 | $141 |
| United Therapeutics Corporation | 1 | $125 |
| Johnson & Johnson | 8 | $103 |
| Regeneron Healthcare Solutions, Inc. | 3 | $89 |
| Gilead | 1 | $84 |
| Sanofi | 3 | $50 |
| Philips North America LLC | 3 | $47 |
| Pfizer | 3 | $39 |
| Electromed, Inc. | 2 | $31 |
| Tetraphase Pharmaceuticals, Inc. | 2 | $29 |
| Merck | 2 | $29 |
| Pulmonx Corporation | 1 | $28 |
| Circassia Inc. | 1 | $12 |
| Mallinckrodt Enterprises LLC | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,170 in reported general payments places this provider in the 60th percentile of 258 pulmonary disease providers in Indiana.
Other pulmonary disease in Indianapolis
- Cynthia BrownIndianapolis$7.3M
- Roberto MachadoIndianapolis$219K
- Michael DuncanIndianapolis$146K
- Gary ZalogaIndianapolis$79K
- Abboud KawakIndianapolis$68K
- Ryan LogueIndianapolis$30K
- George RubeizIndianapolis$24K
- Clare ProhaskaIndianapolis$20K
- Rajat NarangIndianapolis$17K
- Marcus TielkerIndianapolis$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.